Landmark EU General Court Google Android decision signals tougher antitrust enforcement
Google's biggest legal loss to date with a fine of € 4.125 billion - for how it exclusively bundled Google Search and other advertising into Android phones. Encouraging competition and innovation in markets requires determined work by regulators. "On 14 September, the General Court of the European...
Source: hausfeld.com
Facebook faces prospect of 'devastating' data transfer ban after Irish ruling
Ireland's data regulator can resume a probe that may trigger a ban on Facebook's transatlantic data transfers, the High Court ruled on Friday, raising the prospect of a stoppage that the company warns would have a devastating impact on its business.
Source: reuters.com
Why a U.S. hospital and oil company turned to facial recognition
Deployments of facial recognition from Israeli startup AnyVision show how the surveillance software has gained adoption across the United States even as regulatory and ethical debates about it rage.
Source: reuters.com
Preventing critical failure
Can routinely collected data be repurposed to predict avoidable patient harm? A quantitative descriptive study Objectives To determine whether sharing of routinely collected health service performance data could have predicted a critical safety failure at an Australian maternity service. Design Observational...
Source: bmj.com
A critical makeover for pharmaceutical companies: Overcoming industry obstacles with a cross-functional strategy. PwC
A critical makeover for pharmaceutical companies: Overcoming industry obstacles with a cross-functional strategy. PwC report. Going all "cross-functional" or "breaking down silos"?
"Compounding the external obstacles, however, is the internal culture of most pharma companies. This is an industry...
Source: pwc.com
Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review. - PubMed - NCBI "Although
Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review. - PubMed - NCBI "Although social media data has the potential to supplement data from
regulatory agency databases; is able to capture less frequently reported
AEs; and can identify AEs earlier than official...
Source: nih.gov
Continuing professional development: progress beyond continuing medical education: Continuing medical education (CME) is
Continuing professional development: progress beyond continuing medical education: Continuing medical education (CME) is rapidly evolving into competency-based continuing professional development (CPD) and this is driving change in self-directed CPD programs undertaken by individual practitioners as...
Source: amegroups.com
Caldicott's concerns: DeepMind and the Royal Free London - a summary from Mischon de Reya. "The latest medical data sharing
Caldicott's concerns: DeepMind and the Royal Free London - a summary from Mischon de Reya. "The latest medical data sharing controversy to attract the interest of regulators and the press involves the Royal Free London ('RF'), one of London's biggest hospitals, and its arrangements with DeepMind, involving...
Source: mishcon.com
The new survivors and a new era for trauma research: Karim Brohi and Martin Schreiber, Guest Editors of the Special Issue
The new survivors and a new era for trauma research: Karim Brohi and Martin Schreiber, Guest Editors of the Special Issue on Trauma, describe a new era in exploration of the biology of injury response and translation of new opportunities into clinical practice. Karim Brohi. Martin Schreiber. PLOS Medicine....
Source: plos.org
Innovations in Diabetes Care Around the World: Case Studies from Mexico, India, and US of Care Transformation Through Accountable
Innovations in Diabetes Care Around the World: Case Studies from Mexico, India, and US of Care Transformation Through Accountable Care Reforms: A Commonwealth Fund–supported study in Health Affairs examines promising diabetes programs in Mexico, India, and the United States to understand the institutional,...
Source: commonwealthfund.org
If VW can cheat regulators, how many other corporate scams are there out there?: The emissions test scandal at Volkswagen
If VW can cheat regulators, how many other corporate scams are there out there?: The emissions test scandal at Volkswagen is not simply bad for one of the world’s more successful car companies. It has, understandably, led many to wonder if other auto giants have engineered their cars to give misleading...
Source: independent.co.uk
Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS: The issue related to macrovascular
Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS: The issue related to macrovascular outcomes and intensive glycemic control was hotly debated after the publication of landmark trials like ACCORD, ADVANCE, and VADT. The only benefits seem to come from intervening...
Source: hindawi.com
RSS feed